Estimating Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Using Linked Public Health Information Systems, California, 2023–2024 Season
The Journal of Infectious Diseases · 14.11.2025 · 232 (5) · 1249-1257
DOI: 10.1093/infdis/jiaf248 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 13.05.2025. Verfasst von Sophie Zhu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines, Vaccine Efficacy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.
Abstract (Originalsprache)
Background
Mandatory public health reporting of influenza laboratory results and vaccine doses administered in the state of California can provide estimates of seasonal influenza vaccine effectiveness (VE).
Methods
We analyzed linked influenza immunization registry and laboratory reporting data among California residents aged ≥6 months tested for influenza during the 2023–2024 influenza season (October 2023 to June 2024). Individually linked laboratory reporting included influenza molecular or viral culture test result. Odds ratios (OR) and 95% confidence intervals (CI) contrasted odds of documented 2023–2024 vaccination among persons with influenza-positive tests versus persons with negative influenza tests. VE was calculated as (1 − adjusted OR) × 100 using logistic regression, adjusting for patient age, race, ethnicity, week of specimen collection, and county of residence.
Results
Among 1 382 142 laboratory reports, 129 253 persons (9%) had a positive influenza test result, of whom 415 390 (30%) had documented influenza vaccination ≥ 14 days before test date. VE against laboratory-confirmed influenza was 41% (95% CI, 40%–42%). VE was 32% (95% CI, 31%–33%) against influenza A, 68% (95% CI, 66%–69%) against influenza B, and 26% (95% CI, 24%–29%) among adults aged ≥ 65 years.
Conclusions
Influenza vaccination was associated with prevention of laboratory-confirmed influenza. Results demonstrated the feasibility of assessing seasonal influenza VE using linked immunization and laboratory data from public health surveillance systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- California Department of Public Health, Richmond, California, USA.
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
ORCID-Profile: Sophie Zhu, Monica Sun, Nancy J Li, Cynthia Yen, Brendan Flannery, Erin L Murray
Förderung
- Intramural CDC HHS
Zitieren
APA
Zhu, S., Quint, J., León, T. M., Sun, M., Li, N. J., Yen, C., Tenforde, M. W., Flannery, B., Jain, S., Schechter, R., Hoover, C., & Murray, E. L. (2025). Estimating Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Using Linked Public Health Information Systems, California, 2023–2024 Season. The Journal of Infectious Diseases, 232(5), 1249-1257. https://doi.org/10.1093/infdis/jiaf248
Vancouver
Zhu S, Quint J, León TM, Sun M, Li NJ, Yen C, et al. Estimating Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Using Linked Public Health Information Systems, California, 2023–2024 Season. The Journal of Infectious Diseases. 2025;232(5):1249-1257. doi:10.1093/infdis/jiaf248
BibTeX
@article{Zhu2025,
author = {Zhu, Sophie and Quint, Joshua and León, Tomás M and Sun, Monica and Li, Nancy J and Yen, Cynthia and Tenforde, Mark W and Flannery, Brendan and Jain, Seema and Schechter, Robert and Hoover, Cora and Murray, Erin L},
title = {Estimating Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Using Linked Public Health Information Systems, California, 2023–2024 Season},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {232},
number = {5},
pages = {1249--1257},
doi = {10.1093/infdis/jiaf248}
}
EUVIMED